Published on Thursday April 01, 2021
We are working on the following new projects:
- Smooth was awarded by 5 projects for medical writing and data management in CEE.
We are happy to reach the following milestones in our projects:
- All sites were closed in the III phase trial with Risperidone.
- All patients are enrolled in the Acetylcysteine trial in rhinosinusitis in March.
- All sites were opened in a III phase trial with Nimesulide.
- CSR was approved by the Sponsor in the Nadroparin trial.
- The site was opened in the Dutasteridum + Tamsulosinum bioequivalence study.
We successfully passed ISO certification by G-CERTI (S. Korea) for the following standards:
- ISO 9001:2015 "Quality Management Systems".
- ISO 27001:2013 "Information Security Management Systems".
- ISO 22301:2019 "Business Continuity Management Systems".